CMS-PB: the cash flow

MyFinsight

For the year ending 2025-12-31, CMS-PB had $437M increase in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Net income	1,002
Depreciation and amortization	1,306
Deferred income taxes and investment tax credits	202
Bad debt expense	40
Postretirement benefits contributions	16
Other noncash operating activities and reconcilingadjustments	238
Accounts receivable and accrued revenue	251
Inventories	28
Accounts payable and accrued rate refunds	196
Other current assets and liabilities	-78
Other noncurrent assets and liabilities	56
Net cash provided by operating activities	2,235
Capital expenditures (excludes assets placed under finance lease)-Ongoing Capital Expenditures	3,824
Capital expenditures (excludes assets placed under finance lease)-Covert Plant Acquisition	0
Proceeds from sale of asp business	0
Cost to retire property and other investing activities	214
Net cash used in investing activities	-4,038
Proceeds from issuance of debt	3,609
Retirement of debt	1,150
Increase (decrease) in notes payable	-65
Issuance of common stock	525
Payment of dividends on common and preferred stock	663
Proceeds from the sale of membership interests in vies-Class BMembership	44
Proceeds from the sale of membership interests in vies-Class ATax Equity Membership	15
Contributions from noncontrolling interests	4
Distributions to noncontrolling interests	14
Other financing costs	-65
Net cash provided by financing activities	2,240
Net increase (decrease) in cash and cash equivalents,including restricted amounts	437
Cash and cash equivalents at beginning of period	178
Cash and cash equivalents at end of period	615

Unit: Million (M) dollars (except for numbers of shares and EPS).